BioCentury
ARTICLE | Clinical News

Esprolol: Phase IIb

December 20, 1999 8:00 AM UTC

In a Phase IIb study, esprolol gave a significant improvement in exercise parameters including exercise duration and time to onset of angina pain and ischemia compared to placebo when given 30 or 120 ...